Sapient Discovery LLC
President and Chief Scientific Officer
Kal Ramnarayan is the founder, President, Chief Scientific Officer of Sapient Discovery. Previously, he co-founded Structural Bioinformatics, Inc. and Cengent Therapeutics. Prior to Structural Bioinformatics, Inc., he was head of Computational Chemistry at Immuno Pharmaceutics Inc., where he designed numerous drug leads, including highly specific endothelin; a receptor antagonists. This became Sitaxsentan, currently in Phase III clinical development by Encysive Pharmaceuticals. He holds a Ph.D. in Molecular Biophysics from the Indian Institute of Science, Bangalore and has multiple papers and patents and several other patents pending. He is also co-founder of Focus Synthesis, LLC, in San Diego.
Experineced in Bioinformatics, Structure Guided Drug Discovery, Chemoinformatics, Molecular Biophysics and Computational Chemistry.